ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

This study has been completed.
Sponsor:
Collaborator:
Abbott Vascular
Information provided by (Responsible Party):
Detlef Mathey, Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.
ClinicalTrials.gov Identifier:
NCT01583608
First received: April 17, 2012
Last updated: December 8, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)